Based in the USA, Diagnosys aims to improve ways to diagnose retinal disorders, investigate unexplained visual loss, aid in drug discovery, ensure that drugs coming to market don’t have an adverse effect on vision, monitor progressive visual disorders, screen for inherited retinal diseases and more.

Founded in 1996 through a collaboration between Doran Instruments and Cambridge Research Systems, Diagnosys aims to draw on an extensive experience in vision science and engineering. An industry leader in the field of ophthalmic electrophysiology, Diagnosys equipment is designed to broaden accessibility to functional testing, and to bring these powerful diagnostic tools into the clinic.